Tsumura & Co. (TSMRF)
PNK: TSMRF
· Real-Time Price · USD
28.15
0.00 (0.00%)
At close: Apr 30, 2025, 8:00 PM
Company Description
Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide.
The company offers Kampo extract intermediates and granular Kampo formulations.
It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products.
The company was founded in 1893 and is headquartered in Tokyo, Japan.
Tsumura & Co.

Country | JP |
IPO Date | Feb 22, 2013 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 4,138 |
CEO | Terukazu Kato |
Contact Details
Address: 2-17-11, Akasaka Tokyo, JP | |
Website | https://www.tsumura.co.jp |
Stock Details
Ticker Symbol | TSMRF |
Exchange | PNK |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | n/a |
CUSIP Number | n/a |
ISIN Number | JP3535800001 |
Employer ID | - |
SIC Code | n/a |
Key Executives
Name | Position |
---|---|
Terukazu Kato | President, Chief Executive Officer & Chairman |
Kei Sugii | Co-Chief Operating Officer & Director |
Koin Toda | Co-Chief Operating Officer |
Muneki Handa | Chief Financial Officer & Director |
Kouji Shiseki | Executive Officer and GM of Legal & Compliance Control Department |
Makoto Kitamura | Head of Corporate Communications Dept. |
Susumu Adachi | Chief Human Resources Officer |
Tadahiro Abe | GM of Healthcare Division & Executive Officer |
Yukinori Sorata | Executive Officer & GM of Prescription Pharmaceutical Sales Division |
Zhang Liqing | Executive Officer |